Recent studies have shown that the phosphatidylinositol 3-kinase (PI3K) signalling cascade is frequently overactivated in human cancer [6]–[8] playing a critical role both in the initiation and progression of NSCLC [9], [10]. This evidence concerns the gene PIK3CG and cancer.